CLASS II Drug recall · Reported 29 Mar 2017 · FDA Enforcement Report

Atenolol Tablets, USP, 50 mg recalled by Zydus Pharmaceuticals USA

Zydus Pharmaceuticals USA is recalling Atenolol Tablets, USP, 50 mg, distributed nationwide in the US. The recall was initiated on 6 Mar 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18
NDC68382-022, 68382-023, 68382-024
Quantity recalled9561 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0605-2017
FDA event ID
76673
Recalling firm
Zydus Pharmaceuticals USA, Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class II
Status
Terminated
Recall initiated
6 Mar 2017
FDA classified
21 Mar 2017
Reported
29 Mar 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

6 Mar 2017Recall initiated by company
21 Mar 2017Classified by FDA+15 days
29 Mar 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Where it was distributed

Nationwide in the USA and Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Which lots are affected?

Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18

Where was it sold?

Nationwide in the USA and Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals USA

All 41

Other Atenolol recalls

All 5